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Abstract The neuron-specific RC3/neurogranin gene is regu-
lated by thyroid hormone at the transcriptional level in brain and
in cultured neuronal cells. Regulation in vivo displays exquisite
regional selectivity which is not due to differential distribution of
thyroid receptors and is most probably related to region-specific
trans-acting elements. We have previously identified an intronic
thyroid hormone responsive element in the human RC3 gene
homolog, NRGN. In a search for cis-acting elements that might
contribute to the specificity of thyroid regulation, we have
identified a novel sequence, TTCCAAAATGG, which binds to a
developmentally regulated protein, and interferes with T3
transactivation.
z 1999 Federation of European Biochemical Societies.
Key words: Thyroid hormone; Brain gene expression;
Development; Nuclear receptor; Southwestern blotting
1. Introduction
Mammalian brain maturation is critically dependent on
thyroid hormones (thyroxine, T4 and 3,5,3P-triiodothyronine,
or T3). The active form of thyroid hormone, T3, binds to
nuclear receptors [1], which are ligand-modulated transcrip-
tion factors of the steroid hormone superfamily. T3 receptors
(TR) bind target genes through speci¢c DNA sequences
known as T3 responsive elements (TRE). These elements usu-
ally recognize heterodimers between the TR and the 9-cis
retinoic acid receptor, RXR [2]. In addition to RXR, other
molecular entities participate in the action of T3, namely co-
repressors and coactivators which transduce the signal from
the unliganded or liganded TR to the basal transcriptional
machinery [3^5].
In brain, thyroid hormone coordinates the expression of
target genes during development and in di¡erent regions, so
that gene expression occurs in an orderly fashion during ma-
turation [6,7]. One important question is how regional selec-
tivity in thyroid hormone control of target genes is achieved.
The problem can be illustrated from our previous studies of
the control of the neuronal gene RC3/neurogranin [8]. Thy-
roid hormone regulates RC3 expression only in discrete re-
gions, namely the caudate, the granular cell layer of the hip-
pocampus, neocortical layer 6 and retrosplenial cortex. Other
regions are insensitive, for example amygdala, upper layers of
the cortex and pyramidal layer of the hippocampus, [9]. There
is yet no explanation for this di¡erential sensitivity of diverse
neuronal populations. RC3 is a primary transcriptional re-
sponse to T3 [10,11], and therefore additional cofactors are
likely to be involved in the determination of the regional
sensitivity to thyroid hormone. It is therefore of great interest
to identify such putative cofactors since they likely act
through modulation of the action of thyroid hormone and
other epigenetic factors.
We have recently shown that the human RC3 homolog,
NRGN, contains a TRE in the ¢rst intron [12]. This element
was identi¢ed as a direct repeat of the consensus hexameric
sequence AGGTCA separated by four nucleotides (DR4), as
in other T3 regulated genes. This element was able to modu-
late the activity of a reporter gene under control of either
homologous or heterologous promoters. In this paper we
show that a sequence adjacent to the TRE binds a nuclear
protein which interferes with T3 transactivation. Such a pro-
tein altogether with the cis-element where it binds to are likely
involved in the regional speci¢city and/or timing of thyroid
hormone action.
2. Materials and methods
2.1. Plasmids and oligonucleotides
The following plasmids were used in this study: pBLCAT-2, a
chloramphenicol acetyl transferase (CAT) expression vector driven
by the thymidine kinase (tk) promoter; a rat T3 receptor K-1 isoform
in pCDM8, a gift from Dr. P.R. Larsen (Brigham and Women’s
Hospital, Boston, MA, USA); human RXRK expression vector in
pSG-5, supplied by Dr. H. Stunnenberg (University of Nijmegen,
The Netherlands). The oligonucleotides used for the gel retardation
experiments were synthesized as two complementary strands with 5P
extensions. The TRE-containing oligonucleotides were synthesized
according to the sequences of the NRGN TRE [12] and the TRE
present in the long terminal repeat of the Moloney murine leukemia
virus (Mo) [13], as follows (the half sites of the TREs are under-
lined):
NRGN TRE: 5P-TCGACTTCCAAAATGGGGATTAAATGA-
GGTAATATC-3P
Mo TRE: 5P-TCGACAGGGTCATTTCAGGTCCTTGC-3P
NR-Mo: 5P-TCGACTTCCAAAATGGGGATTGGGTCATTTC-
AGGTCCTTGC-3P
The mutated oligonucleotides were variants of the NRGN TRE
with the indicated modi¢cations (nucleotide substitutions are in
italics):
M1: 5P-TCGACTTCCAAAATGGTTATTAAATGAGGTAAT-
ATC-3P
M2: 5P-TCGACTTCCAAAATGGGGATTAAATGATTTAAT-
ATC-3P
M4: 5P-TCGACGATCCAAGAGGGATTAAATGAGGTAATA-
TC-3P
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And the mutated oligonucleotide of the NR-Mo:
M4-Mo: 5P-TCGACGATCCAAGAGGGATTGGGTCATTTCA-
GGTCCTTGC-3P
Non-speci¢c oligonucleotide (NS):
NS: 5P-GATCCAAGAGTTTGACTGGCTGATTTCCAGTTT-
GTG-3P
The oligonucleotide NS-x contains the TTCCAAAATGG sequence
inserted in the NS sequence:
NS-x: 5P-GATCCAAGAGTTTGACTTCCAAAATGGCAGTT-
TGTG-3P
For Southwestern blotting the double-stranded oligonucleotide 5P-
AGCTTTCCAAAATGGTTCCAAAATGG-3P was self ligated to
prepare a probe containing tandem copies of the sequence.
For transactivation experiments, a single copy of each of the Mo
TRE, NR-Mo and M4-Mo oligonucleotides was subcloned into the
SalI site of pBLCAT-2 vector.
2.2. Cell cultures and transient transfection assays
COS7 and N2a cells were grown in Dulbecco’s modi¢ed Eagle’s
medium supplemented with 10% fetal bovine serum. GT1-7 cells
were grown in modi¢ed Eagle’s medium supplemented with 5% fetal
bovine serum and 5% horse serum. Transfections and T3 treatment of
the cultures were done as described in detail [10,14].
2.3. Isolation of nuclear extracts
Cells were harvested, resuspended in ice-cold hypotonic bu¡er
(10 mM HEPES KOH pH 7.9, 1.5 mM MgCl2, 10 mM KCl, 1 mM
dithiothreitol (DTT), 0.5 mM phenylmethanesulfonyl £uoride
(PMSF)) incubated in ice for 10 min and centrifuged. The pellets
were resuspended, incubated for another 20 min in ice in 50 ml of a
hypertonic bu¡er (20 mM HEPES KOH pH 7.9, 25% glycerol,
420 mM NaCl, 1.5 mM MgCl2, 0.2 mM EDTA, 1 mM DTT,
0.5 mM PMSF) and centrifuged. The supernatants were aliquoted
and stored at 370‡C. Rat brain nuclear extracts were prepared by
resuspending puri¢ed nuclei in lysis bu¡er (400 mM KCl, 25% glyc-
erol, 1.5 mM MgCl2, 0.2 mM EDTA, 20 mM HEPES KOH pH 7.9,
0.5 mM DT, 0.2 mM PMSF, 2.5 mg/ml leupeptin, 10 mg/ml STI).
2.4. Electrophoretic mobility shift assays (EMSA)
TR and RXR were synthesized using the TNT0 kit (Promega, TNT
Sp6 Coupled Reticulocyte Lysate system). Double stranded oligonu-
cleotides were labelled with T4 Polynucleotide Kinase and [Q-32P]ATP,
and puri¢ed with QIAquick Nucleotide Removal0 kit (Qiagen). The
EMSA procedure was exactly as described [12].
2.5. Southwestern blotting
Complementary oligonucleotides were annealed, phosphorylated,
and ligated for 12 h at 15‡C. The concatenated DNA (500 ng) was
labelled by random priming with 50 WCi [K-32P]dCTP. Nuclear ex-
tracts (50 Wg protein) were boiled for 10 min in 6% SDS and 60 mM
DTT and electrophoresed in a 5^10% polyacrylamide gradient gel in
the presence of 10% SDS. The proteins were transferred to a nylon
membrane (Immobilon; Millipore) in 20% methanol, 25 mM Tris,
0.2 M glycine by electrotransfer at 300 mA for 1 h. The ¢lters were
washed in binding bu¡er (40 mM HEPES pH 7.9, 200 mM KCl, 1 mM
EDTA, 1 mM DTT) containing 6 M guanidine HCl, and then
gradually renatured by ¢ve washes using serial two-fold dilutions of
the guanidine HCl in binding bu¡er, with a ¢nal incubation in binding
bu¡er. All washes were for 10 min at 4‡C. The ¢lters were blocked in
5% non-fat dry milk in binding bu¡er for 30 min at 4‡C and then
hybridized overnight at 4‡C in binding bu¡er with 0.25% non-fat dry
milk and 1U106 cpm/ml of the labelled probe. The unbound probe
was washed away by incubation in the latter solution for 45 min at
4‡C, and the blots were exposed to X-ray ¢lms for autoradiography.
3. Results and discussion
We have shown previously that the NRGN gene contains a
Fig. 1. EMSA demonstrating binding of nuclear proteins to the
NRGN TRE oligonucleotide. The labelled NRGN TRE oligonu-
cleotide was used as a probe. It was incubated with in vitro trans-
lated TR and RXR (lanes 1 and 5) or with nuclear extract from
GT1-7 cells (lanes 2^4, 6 and 7) or a mixture of both (lane 8). C1
is the band produced in the presence of TR and RXR. C2 is the
band produced in the presence of nuclear extract. NS: non-speci¢c
oligonucleotide. Mo: prototypical DR4 TRE present in the long ter-
minal repeat of the Moloney murine leukemia virus.
Fig. 2. Binding of nuclear proteins to NRGN TRE in the presence
and absence of TRE half site mutants M1 and M2. A mutation in
the second half site of the NRGN TRE abolished binding of TR/
RXR but not of nuclear proteins.
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functional TRE in the ¢rst intron [12]. Fig. 1 shows that using
this element as a labelled probe, an electrophoretically re-
tarded band (C1, lane 1) is produced when incubated with
in vitro translated TR and RXR. However, when the same
probe was incubated with nuclear extracts from hypothalamic,
thyroid hormone-responsive GT1-7, a faster migrating band
(C2, lane 2) was observed. This band was speci¢c since it was
not competed by excess of an unrelated sequence (lane 3), but
was greatly reduced in the presence of an excess NRGN TRE
oligonucleotide (lane 4). In contrast the C2 band was not
obliterated by incubation with the strong TRE present in
the Moloney murine leukemia virus LTR (Mo; Fig. 1, lane
7). Exactly the same results were obtained using extracts from
the neuroblastoma cell line N2a. The result of these experi-
ments suggested the presence of nuclear proteins in the cell
extracts that bind speci¢cally the NRGN TRE oligonucleotide
with a di¡erent speci¢city than the TR-RXR heterodimer.
Incubating the labelled NRGN TRE oligonucleotide with a
mixture of both, TR/RXR and GT1-7 nuclear extract led to
formation of two major shifted bands, corresponding to C1
and C2 (Fig. 1 lane 8). This result suggested that the oligo-
nucleotide probe bound either the receptor heterodimer or the
nuclear extract protein, since the mobility of the C1 and C2
bands was not changed, and no higher mobility complexes
were observed.
To learn more about the binding speci¢city of both sets of
proteins we set out experiments in which the labelled NRGN
TRE was incubated with either TR/RXR or nuclear extracts
in the absence or presence of competitors. As competitors we
used the wild type or mutated versions of the NRGN TRE
sequence, as shown in Fig. 2. In presence of TR/RXR, the
heterodimeric band (C1) was obliterated by the wild type
oligonucleotide, or by a mutated version (M1) containing a
nucleotide substitution in the 5P half site, but not by M2,
which contains a mutation in the 3P half site. These data are
consistent with previous results [12] which showed the impor-
tance of the 5P half site of the TRE. In contrast, formation of
the C2 complex (Fig. 2, right panel) took place in the presence
of nuclear extracts, and was obliterated by either the NRGN
TRE wild type, or by the mutated versions. These results
strongly suggested that the nuclear protein did not bind to
the DR4 element, but to the sequence TTCCAAAATGG,
located 5P to the TRE in the oligonucleotide used for the
EMSA experiments.
We checked whether this sequence was able to bind nuclear
proteins, and in£uence T3-mediated transactivation when
Fig. 3. A: Sequences of the oligonucleotides used in the experiments. B: EMSA using three of the oligonucleotides as probes, after incubation
with the TR/RXR, or with GT1-7 nuclear extract. C: CAT reporter activity after transient transfection in GT1-7 cells. D: Southwestern analy-
sis of nuclear proteins using the TTCCAAAATGG sequence as a probe.
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placed adjacent to a strong TRE such as the Mo TRE (NR-
Mo, Fig. 3A). Using the native NRGN oligonucleotide as a
probe (Fig. 3B), a heterodimer band was again observed in
the presence of in vitro translated TR/RXR (C1), or a faster
migrating band (C2) in the presence of GT1-7 cell nuclear
extract. The Mo TRE behaved similarly to NRGN when
the TTCCAAAATGG sequence was placed adjacent to the
DR4. In addition, when this sequence in the NRGN TRE
native oligonucleotide was replaced by a di¡erent but closely
related sequence (Fig. 3A, M4-NRGN) the heterodimer band
was still present, obviously due to intact DR4, but the faster
migrating C2 band was absent.
As an attempt to functionally correlate binding with trans-
activation we used tk-CAT reporter vectors with either the
native Mo TRE or the NR-Mo TRE (see Fig. 3A) located
upstream from the tk promoter. These reporter constructs
were used for transactivation assays in GT1-7 cells with or
without expression vectors for TR and RXR. CAT activity
was measured after incubating cells in the absence or presence
of T3 (Fig. 3C). Since GT1-7 cells contain physiological
amounts of functional TR and RXR [10], the cells transfected
with the Mo-tk-CAT construct responded to the addition of
T3 with an increased CAT activity. Addition of expression
vectors encoding TR and RXR resulted, as expected, in a
decreased basal expression of the reporter, due to the repres-
sor activity of unliganded receptors, but not in higher T3
stimulation. In contrast, cells transfected with NR-Mo-tk-
CAT did not respond to T3 unless cotransfected with exoge-
nous receptors. The mutated version of this construct (M4-
Mo) behaved as the Mo-tk-CAT construct. These data dem-
onstrate that an endogenous nuclear protein binds to the
TTCCAAAATGG sequence, then interfering with activation
by endogenous RXR/TR receptors.
The molecular mass of the nuclear protein present in the C2
complex was estimated by Southwestern analysis (Fig. 3D).
Nuclear proteins were prepared from COS7, GT1-7 and N2a
cells, fractionated by SDS-polyacrylamide gel electrophoresis
and transferred to a nylon membrane. The protein blot was
probed with a labelled oligonucleotide containing tandem
copies of the TTCCAAAATGG sequence. After hybridization
a single band of Mr 121 000 was identi¢ed in GT1-7 and in
N2a, but not in COS7 nuclear protein extracts. A band with
the same electrophoretic mobility was also present in nuclear
extracts from cerebral cortex.
Presence of the C2 complex varies during development, as it
is revealed by analysis of nuclear proteins harvested from total
embryonal brain (E-19) and from cerebral cortex and cerebel-
lum from rats at di¡erent postnatal ages. The extracts were
analyzed by EMSA (Fig. 4) after incubation with a labelled
oligonucleotide containing the TTCCAAAATGG sequence
(NS-x), either in the absence or in the presence of an excess
unlabelled oligonucleotide. As expected, the shifted band pro-
duced using nuclear extracts from N2a cells showed up (Fig.
4). Nuclear extracts from rat brain produced a similar band
with extracts from either E-19 embryos or cerebral cortex of
postnatal days 5 and 15 (Ctx-5 and Ctx-15, respectively). The
band was also produced with the postnatal day 15 cerebellum
(Cb-15) but not with cerebral cortex or cerebellum from adult
rats (Ctx-60, Ctx-90, Cb-60).
These experiments showed that the sequence TTCC-
AAAATGG, present in the ¢rst intron of the human neuro-
granin gene, speci¢cally binds a nuclear protein of Mr 121 000.
Binding of this protein in a position which is adjacent to the
TRE interferes with TR/RXR-dependent transactivation by
T3. It is known that the extent of transactivation by T3 in
cells overexpressing TR and RXR is very variable among
di¡erent cell lines [15], suggesting that cell factors other
than the receptors may limit the T3 response. These factors
which may not necessarily interact with the T3 receptors, but
with the target gene, are likely to modify the hormonal re-
sponse [16^19]. The protein identi¢ed here shares most of the
properties de¢ned for such factors. Moreover, it is develop-
mentally regulated, since it is more abundantly expressed in
young animals than in adult animals. Recently COUP-TF,
another developmentally regulated protein, has been shown
to antagonize the action of T3 in embryonal and neonatal
rat brain [20]. To precisely de¢ne the physiological role of
the 121 000-Mr protein in NRGN expression and T3 regula-
tion, cloning of this protein is currently in progress in our
laboratory.
Acknowledgements: Supported by Fundacio¤n Ramo¤n Areces and CI-
CYT PM98-0118. B.M. and J.M. were supported by the Comunidad
de Madrid and CMA was a predoctoral fellow from the Basque Gov-
ernment. We thank Fernando Nun‹ez and Pablo Sen‹or for the care of
animals, and Gloria Chaco¤n for technical help.
References
[1] Lazar, M.A. (1993) Endocr. Rev. 14, 184^193.
[2] Glass, C.K. (1994) Endocr. Rev. 15, 391^407.
[3] Chen, J.D. and Evans, R.M. (1995) Nature 377, 454^457.
[4] Ho«rlein, A.J., Na«a«r, A.M., Heinzel, T., Torchia, J., Gloss, B.,
Kurokawa, R., Ryan, A., Kamei, Y., So«derstro«m, M., Glass,
C.K. and Rosenfeld, M.G. (1995) Nature 377, 397^403.
[5] Horwitz, K.B., Jackson, T.A., Bain, D.L., Richer, J.K., Takimo-
to, G.S. and Tung, L. (1996) Mol. Endocrinol. 10, 1167^1177.
[6] Porter¢eld, S.P. and Hendrich, C.E. (1993) Endocr. Rev. 14, 94^
106.
[7] Bernal, J. and Nunez, J. (1995) Eur. J. Endocrinol. 133, 390^
398.
[8] Gerendasy, D.D. and Sutcli¡e, J.G. (1997) Mol. Neurobiol. 15,
131^163.
Fig. 4. EMSA using nuclear extracts from N2a cells, embryonal rat
brain (E-19), cerebral cortex (Ctx) of postnatal days 5, 15, 60 and
90 and cerebellum of postnatal days 15 and 60. Competition assays
were performed with a 200-fold molar excess of the unlabelled oli-
gonucleotide.
FEBS 23134 22-12-99
B. Morte et al./FEBS Letters 464 (1999) 179^183182
[9] In‹ iguez, M.A., De Lecea, L., Guadan‹o-Ferraz, A., Morte, B.,
Gerendasy, D., Sutcli¡e, J.G. and Bernal, J. (1996) Endocrinol-
ogy 137, 1032^1041.
[10] Morte, B., In‹ iguez, M.A., Lorenzo, P.I. and Bernal, J. (1997)
J. Neurochem. 69, 902^909.
[11] Guadan‹o-Ferraz, A., Escamez, M.J., Morte, B., Vargiu, P. and
Bernal, J. (1997) Mol. Brain Res. 49, 37^44.
[12] Mart|¤nez de Arrieta, C., Morte, B., Coloma, A. and Bernal, J.
(1999) Endocrinology 40, 335^343.
[13] Sap, J., Mun‹oz, A., Schmitt, J., Stunnenberg, H. and Vennstrom,
B. (1989) Nature 340, 242^244.
[14] Sambrook, J., Fritsch, E.F. and Maniatis, T. (1989) Molecular
cloning: A Laboratory Manual, 2nd edn., Cold Spring Harbor
Laboratory Press, Cold Spring Harbor, NY.
[15] Hayashi, Y., Yamaguchi, S., Pohlenz, J., Murata, Y., Refeto¡, S.
and Seo, H. (1997) Mol. Cell. Endocrinol. 131, 59^66.
[16] Hagen, S.G., Larson, R.J., Strait, K.A. and Oppenheimer, J.H.
(1996) J. Mol. Neurosci. 7, 245^255.
[17] Anderson, G.W., Hagen, S.G., Larson, R.J., Strait, K.A.,
Schwartz, H.L., Mariash, C.N. and Oppenheimer, J.H. (1997)
Mol. Cell. Endocrinol. 131, 79^87.
[18] Thurmond, D. and Goodbridge, A. (1998) J. Biol. Chem. 273,
1613^1622.
[19] Huo, B., Dozin, B. and Nikodem, V.M. (1997) Endocrinology
138, 3283^3289.
[20] Anderson, G.W., Larson, R.J., Oas, D.R., Sandhofer, C.R.,
Schwartz, H.L., Mariash,,C.N. and Oppenheimer, J.H. (1998)
J. Biol. Chem. 273, 16391^16399.
FEBS 23134 22-12-99
B. Morte et al./FEBS Letters 464 (1999) 179^183 183
